Stockreport

ImmunityBio: Anktiva's Launch Demands A Reassessment [Seeking Alpha]

ImmunityBio, Inc.  (IBRX) 
PDF The company is well-prepared for the launch, with a strong sales force, established distribution channels, and sufficient inventory. Analyst projections suggest signi [Read more]